MedPath

Diazepam

diazePAM injection, USP

Approved
Approval ID

83646a0f-eb43-4871-b95e-683c2533d2be

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 2, 2023

Manufacturers
FDA

Civica, Inc.

DUNS: 081373942

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

DIAZEPAM

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code72572-140
Application NumberANDA210363
Product Classification
M
Marketing Category
C73584
G
Generic Name
DIAZEPAM
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateSeptember 25, 2023
FDA Product Classification

INGREDIENTS (6)

DIAZEPAMActive
Quantity: 10 mg in 2 mL
Code: Q3JTX2Q7TU
Classification: ACTIB
BENZYL ALCOHOLInactive
Code: LKG8494WBH
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
ALCOHOLInactive
Code: 3K9958V90M
Classification: IACT
SODIUM BENZOATEInactive
Code: OJ245FE5EU
Classification: IACT
BENZOIC ACIDInactive
Code: 8SKN0B0MIM
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Diazepam - FDA Drug Approval Details